Lu Zhou

900 total citations
50 papers, 683 citations indexed

About

Lu Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lu Zhou has authored 50 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Lu Zhou's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Lu Zhou is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Lu Zhou collaborates with scholars based in China, United States and Netherlands. Lu Zhou's co-authors include Xinghua Lu, Fei Jia, Tao Liu, Zhaohui Lu, Wei Fu, Deyong Ye, Shanshan Lai, Peng‐Hui Wang, Xiujun Fan and Yong Kyu Chu and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Lu Zhou

47 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Zhou China 17 314 133 127 108 84 50 683
Reyaz ur Rasool India 17 370 1.2× 174 1.3× 97 0.8× 64 0.6× 69 0.8× 26 694
Liyan Ji China 15 332 1.1× 143 1.1× 104 0.8× 77 0.7× 101 1.2× 30 644
Xiaodan Sun China 14 304 1.0× 113 0.8× 121 1.0× 95 0.9× 32 0.4× 39 556
Jin Ando Japan 12 460 1.5× 104 0.8× 126 1.0× 322 3.0× 25 0.3× 23 810
Yi-Min Liu Taiwan 16 535 1.7× 175 1.3× 82 0.6× 61 0.6× 211 2.5× 22 996
Liyan Chen China 18 581 1.9× 160 1.2× 164 1.3× 69 0.6× 55 0.7× 33 851
Wenbin Song China 19 540 1.7× 245 1.8× 213 1.7× 68 0.6× 45 0.5× 36 985
Youqun Xiang China 17 347 1.1× 250 1.9× 150 1.2× 57 0.5× 51 0.6× 30 734
Jing Ding China 15 588 1.9× 105 0.8× 337 2.7× 66 0.6× 27 0.3× 37 844

Countries citing papers authored by Lu Zhou

Since Specialization
Citations

This map shows the geographic impact of Lu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Zhou more than expected).

Fields of papers citing papers by Lu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Zhou. The network helps show where Lu Zhou may publish in the future.

Co-authorship network of co-authors of Lu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Zhou. A scholar is included among the top collaborators of Lu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Zhou. Lu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Lu, et al.. (2025). A dual-peptides and specific promoter-modified nano gene delivery system for myocardial hypertrophy treatment. International Journal of Biological Macromolecules. 311(Pt 2). 143759–143759. 2 indexed citations
3.
Yang, Fang, Meijing Wang, Xiaopeng Huang, et al.. (2025). Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives. Frontiers in Pharmacology. 16. 1478331–1478331. 1 indexed citations
4.
Yu, Liang, et al.. (2024). Anti-tumor effects of nanosecond pulsed electric fields in a murine model of pancreatic cancer. Bioelectrochemistry. 161. 108803–108803. 4 indexed citations
5.
Zhou, Lu, et al.. (2022). PertOrg 1.0: a comprehensive resource of multilevel alterations induced in model organisms by in vivo genetic perturbation. Nucleic Acids Research. 51(D1). D1094–D1101. 3 indexed citations
6.
Liu, Fan, et al.. (2022). Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation. Journal of Cancer Research and Clinical Oncology. 149(1). 219–230. 6 indexed citations
7.
Zhou, Lu, Zongjie Gan, Qianyu Zhang, et al.. (2022). Preparation and characterization of a gemini surfactant-based biomimetic complex for gene delivery. European Journal of Pharmaceutics and Biopharmaceutics. 182. 92–102. 15 indexed citations
8.
Tu, Juchuanli, Xue‐Yan He, Bingjie Liu, et al.. (2022). Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer. Acta Pharmaceutica Sinica B. 13(4). 1686–1698. 5 indexed citations
9.
Fan, Jun, Zhe Zhang, Hongqiang Chen, et al.. (2021). Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer. Translational Cancer Research. 10(5). 2286–2304. 3 indexed citations
11.
Zhou, Lu, et al.. (2019). ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ. American Journal of Physiology-Endocrinology and Metabolism. 316(5). E773–E781. 46 indexed citations
12.
Zhou, Lu, Zhi Li, Bowen Yang, et al.. (2019). Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Pathology - Research and Practice. 215(9). 152449–152449. 4 indexed citations
13.
Zhou, Lu, Ming Li, & Tao Zhu. (2019). Comment on ‘Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis’. British Journal of Cancer. 120(11). 1083–1083. 1 indexed citations
15.
Cui, Binxin, Lu Zhou, Samiullah Khan, Jianmin Cui, & Wentian Liu. (2017). Role of enteral nutrition in pancreaticocolonic fistulas secondary to severe acute pancreatitis. Medicine. 96(49). e9054–e9054. 3 indexed citations
16.
Zhou, Lu, et al.. (2016). Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women. Inflammation Research. 65(9). 717–724. 25 indexed citations
17.
Zhou, Lu, et al.. (2015). Discovery of Novel NAMPT Inhibitors Based on Pharmacophore Modeling and Virtual Screening Techniques. Combinatorial Chemistry & High Throughput Screening. 17(10). 868–878. 1 indexed citations
18.
Wang, Chenhong, et al.. (2013). Reduced expression of COMT in placenta correlates with term preeclampsia. Advances in Bioscience and Biotechnology. 4(4). 44–49. 2 indexed citations
19.
Zhou, Lu, Zhaohui Lu, Aiming Yang, et al.. (2007). Comparative proteomic analysis of human pancreatic juice: Methodological study. PROTEOMICS. 7(8). 1345–1355. 42 indexed citations
20.
Zhou, Lu, et al.. (1993). Alpha-Tocopherol Content of Breast Milk in China.. Journal of Nutritional Science and Vitaminology. 39(5). 517–520. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026